Patents by Inventor Yonglian SONG

Yonglian SONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biphenyl compound as immunomodulator, preparation method therefor and application thereof
    Patent number: 11866452
    Abstract: A biphenyl compound represented by formula (I), a preparation method therefor and an application thereof. The present invention also relates to a pharmaceutical composition that comprises the compound as an active ingredient. The compound is a novel small molecule immunomodulator having excellent oral absorption features and can be used for treating and/or preventing various immunity-related diseases.
    Type: Grant
    Filed: October 28, 2021
    Date of Patent: January 9, 2024
    Assignee: Shenzhen Chipscreen Biosciences Co., Ltd.
    Inventors: Qianjiao Yang, Song Shan, Lijun Xin, Desi Pan, Xiaoliang Wang, Yonglian Song, Yu Zhang, Huiyun Huang, Qi Wei, Zhibin Li, Xianping Lu
  • BIPHENYL COMPOUND AS IMMUNOMODULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
    Publication number: 20230365590
    Abstract: A biphenyl compound represented by formula (I), a preparation method therefor and an application thereof. The present invention also relates to a pharmaceutical composition that comprises the compound as an active ingredient. The compound is a novel small molecule immunomodulator having excellent oral absorption features and can be used for treating and/or preventing various immunity-related diseases.
    Type: Application
    Filed: October 28, 2021
    Publication date: November 16, 2023
    Inventors: Qianjiao Yang, Song Shan, Lijun Xin, Desi Pan, Xiaoliang Wang, Yonglian Song, Yu Zhang, Huiyun Huang, Qi Wei, Zhibin Li, Xianping Lu
  • FORMAMIDE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
    Publication number: 20210139454
    Abstract: The present invention relates to a formamide compound, a preparation method therefor and an application thereof. The structure of the compound is shown in formula (I), and the definition of each variable in the formula is as provided in the description. The compound is capable of inhibiting the activity of ASK1 kinase. The compound of the present invention may be used in the treatment/prevention of diseases associated with ASK1 kinase, such as inflammatory diseases, metabolic diseases, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, cancers and other diseases.
    Type: Application
    Filed: April 23, 2019
    Publication date: May 13, 2021
    Applicant: SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
    Inventors: Qianjiao YANG, Xianping LU, Zhibin LI, Desi PAN, Song SHAN, Xiaoliang WANG, Yonglian SONG, Kun ZHANG
  • Urea compound and preparation method and application thereof
    Patent number: 10654815
    Abstract: The present invention relates to a urea compound and a preparation method and an application thereof. The structure of the present compound is represented by formula (I), the definition of each variable in the formula being as described in the description. The compound can block interaction between the PD-1/PD-L1 signalling pathways. The compound of the present invention can be used for treating or preventing diseases related to the signalling pathways, such as cancer, autoimmune disease, chronic infectious disease, and other diseases.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: May 19, 2020
    Assignee: SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
    Inventors: Qianjiao Yang, Xianping Lu, Zhibin Li, Lijun Xin, Yonglian Song, Chao Fu
  • UREA COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF
    Publication number: 20190337906
    Abstract: The present invention relates to a urea compound and a preparation method and an application thereof. The structure of the present compound is represented by formula (I), the definition of each variable in the formula being as described in the description. The compound can block interaction between the PD-1/PD-L1 signalling pathways. The compound of the present invention can be used for treating or preventing diseases related to the signalling pathways, such as cancer, autoimmune disease, chronic infectious disease, and other diseases.
    Type: Application
    Filed: December 27, 2017
    Publication date: November 7, 2019
    Applicant: SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
    Inventors: Qianjiao YANG, Xianping LU, Zhibin LI, Lijun XIN, Yonglian SONG, Chao FU